Exclusive

Publication

Byline

Location

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, June 12 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, June 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, June 12 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, June 12 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More


Clinical Trial: A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07641855) titled 'A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Pr... Read More


Clinical Trial: Digital Support for Multiple Myeloma Quality of Life

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07642362) titled 'Digital Support for Multiple Myeloma Quality of Life' on April 21. Brief Summary: The obje... Read More


Clinical Trial: Pulmonary Artery Pressure in Predicting Pulmonary Embolism in Patients Presenting To The Emergency Department With Dyspnea

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07641400) titled 'Pulmonary Artery Pressure in Predicting Pulmonary Embolism in Patients Presenting To The Em... Read More


Clinical Trial: Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07643012) titled 'Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer' on May 27. Brief Summ... Read More


Clinical Trial: AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07640737) titled 'AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)' on June 03. Brief Summ... Read More


Clinical Trial: CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07643077) titled 'CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GR... Read More